Rallybio founders (L-R): Jeff Fryer, Martin Mackay and Steve Uden
As Sanofi prunes pipeline, ex-Alexion crew at Rallybio picks up anemia drug
More than a year after it bought Kymab for $1.5 billion, Sanofi is getting rid of a preclinical program that came with the deal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
